Alphabet Reports Results… And Pharma Stocks Diverge In Weight Loss Drug Race 2/4/26
Google parent company Alphabet on the move as the tech giant reports results. The details and numbers from their latest quarter, and why tech analyst Gene Munster sees the stock topping the Mag7 group this year. Plus Eli Lilly and Novo Nordisk heading in opposite directions as the weight loss drug race enters its next…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Market Resilience Despite Surge In Yields… And Options Action Ahead Of Micron Results 9/25/26
Meta’s Rally Keeps Rocking… And A Major AI Safety Warning 9/24/26
U.S. 10-Year Yield Hits 19-Year High… And The Ripple Effects From Meta’s Muse 9/23/26
Similar episodes from other shows
More like CNBC's "Fast Money" →
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.